10 employees
TYDOCK PHARMA focuses on the discovery and early development of chemotherapeutic drugs, with particular emphasis on parasitic diseases.
2006
$82K
from 1 investors over 1 rounds
TYDOCK PHARMA raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)